Esketamine side effects are an important consideration for adults seeking treatment for depression, particularly treatment-resistant depression. At SNBCare, we provide REMS-compliant Spravato® (esketamine) therapy administered in-office by licensed behavioral health providers, combined with supportive mental health care and follow-up. Understanding potential side effects, monitoring procedures, and individualized care plans is essential for anyone considering esketamine therapy.

Esketamine (Spravato®) is a prescription-only treatment approved by the FDA for adults with treatment-resistant depression. It is administered in a secure clinical setting, typically as a nasal spray, and is part of a comprehensive mental health approach that may include individual therapy sessions, psychiatry appointments, and telehealth follow-ups.

Understanding Esketamine

Esketamine is a chemically derived form of ketamine, designed specifically for the treatment of depression in adults who have not responded effectively to other antidepressant therapies. Its mechanism involves modulating glutamate in the brain, which differs from traditional antidepressants that target serotonin or norepinephrine. This makes esketamine particularly valuable for adults with treatment-resistant depression.

At SNBCare, esketamine is offered as part of a regulated, in-office program that follows REMS requirements, ensuring patient safety. The therapy is integrated with evidence-informed psychiatric care and ongoing monitoring by licensed providers. Patients are closely observed during and after administration to manage potential side effects effectively.

Why Choose SNBCare for Esketamine Therapy

SNBCare is an established outpatient behavioral health clinic providing care for adults in Massachusetts and Rhode Island. Our licensed providers offer in-person Spravato® therapy at multiple office locations, including Framingham, Natick, and North smith Field.

We emphasize:

• Safety and Compliance: All esketamine therapy follows REMS guidelines. Administration occurs in a controlled environment under professional supervision.
• Individualized Care: Every treatment plan is based on clinical evaluation, patient history, and Licensed Adult-Only Care collaborative decision-making.
• Integrated Mental Health Services: Patients can combine esketamine therapy with psychiatry appointments, individual therapy sessions, and telehealth support for depression and anxiety.
• : SNBCare provides services exclusively to adults physically located in Massachusetts or Rhode Island at the time of their appointment.

Common Esketamine Side Effects

Esketamine therapy is generally well-tolerated when administered under clinical supervision, but like all medications, it can produce side effects. Being informed helps patients expect and manage these effects. Common side effects include:

• Dizziness or lightheadedness – Often occurs during or immediately after nasal spray administration.
• Nausea or vomiting – Usually temporary; hydration and monitoring help manage discomfort.
• Dissociation – Patients may feel a temporary sense of detachment from their body or surroundings, which is closely monitored in-office.
• Blood pressure changes – A temporary increase in blood pressure is common, requiring observation.
• Sedation or fatigue – May occur immediately following administration; patients are monitored before discharge.

It’s important to remember that these side effects are typically short and resolve within hours. SNBCare staff ensure that each patient remains in a safe, comfortable environment until symptoms subside.

Rare or Serious Side Effects

While uncommon, some adults may experience more serious side effects that require immediate attention. These include:

• Severe dissociation or hallucinations
• Persistent elevated blood pressure
• Rapid heart rate or palpitations

SNBCare’s in-office administration ensures that treatments are available immediately if needed. Patients are never left unattended, and follow-up care is scheduled to monitor recovery and overall mental health.

Managing Esketamine Side Effects

Proper management of esketamine side effects involves a combination of professional monitoring, lifestyle strategies, and patient education:

• In-office observation: Patients remain under professional supervision for at least two hours after administration.
• Hydration and nutrition: Proper fluid and meal intake can reduce nausea or dizziness.
• Pacing daily activities: Patients are advised to avoid driving or operating machinery immediately post-treatment.
• Follow-up: Telehealth or in-person follow-up ensures side effects are monitored and addressed.

SNBCare clinicians collaborate with patients to create a comprehensive plan for minimizing discomfort and maximizing treatment benefits.

Esketamine and Other Medications

Esketamine may interact with other psychiatric medications. It is critical that patients provide a full list of current prescriptions during their initial comprehensive psychiatric appointment. Licensed providers at SNBCare carefully review each patient’s medications to prevent interactions and ensure safe co-administration.

• SSRIs, SNRIs, or other antidepressants may be continued, adjusted, or monitored alongside esketamine.
• Patients are evaluated individually to determine optimal timing and dosing.

Medication management is always personalized, guided by clinical appropriateness, and integrated with therapeutic support such as online therapy for depression or telehealth for anxiety.

 Patient Experience at SNBCare

Patients receiving esketamine therapy at SNBCare can expect:

1. Initial Evaluation: Comprehensive psychiatry appointment including medical history, mental health assessment, and review of prior treatments.
2. In-Office Administration: Spravato® is administered in a HIPAA-compliant, safe clinical environment with licensed supervision.
3. Observation: Clinicians monitor for side effects, vital signs, and overall comfort during and after treatment.
4. Follow-Up: In-person follow-up visits help assess mental health progress and manage any lingering side effects.

This structured approach ensures patients feel supported, informed, and safe throughout the therapy process.

Research and Evidence

Esketamine has been evaluated in multiple clinical trials for treatment-resistant depression. Evidence shows:

• Rapid improvement in depressive symptoms for some adults.
• Effectiveness is enhanced when combined with continued antidepressant therapy and mental health support.
• Side effects are generally temporary and manageable under clinical supervision.

SNBCare integrates this evidence with personalized care, emphasizing that therapy, medication, and side effect management are provider-dependent and individualized.

 Compliance and Safety Measures at SNBCare

SNBCare maintains strict compliance to regulatory standards:

• REMS-compliant Spravato® therapy
• HIPAA-compliant
• Adult-only patient scope
• Clinical evaluation prior to every administration

Every treatment decision is guided by licensed clinicians, ensuring patient safety and compliance to ethical and legal standards.

Conclusion

Esketamine side effects are an essential consideration for adults exploring treatment-resistant depression options. When administered under professional supervision at SNBCare, Spravato® provides a regulated, evidence-informed treatment option integrated with comprehensive mental health care. Patients receive careful monitoring, individualized treatment plans, and follow-up to manage side effects and support overall well-being.

Adults in Massachusetts and Rhode Island who are ready to explore esketamine therapy can schedule an appointment or speak with a behavioral health provider at SNBCare for guidance.

Disclaimer

This content is for informational and promotional purposes and is sponsored by SNBCare, a licensed behavioral health provider in Massachusetts and Rhode Island. It is not a substitute for professional medical advice, diagnosis, or treatment. All treatments, including REMS-compliant Spravato® therapy, are prescription-only, regulated, and must be administered by licensed providers. Services are available only to adults physically located in Massachusetts or Rhode Island at the time of their appointment.